The global Polio Vaccine market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Sanofi
Bio-Med
Serum Institute
GSK
Panacea Biotec Ltd
Bibcol
IMBCA
Tiantan Biological
Halfkin Bio-Pharmaceuticals
By Types:
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
By Applications:
Public
Private
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Polio Vaccine Market Size Analysis from 2022 to 2027
1.5.1 Global Polio Vaccine Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Polio Vaccine Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Polio Vaccine Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Polio Vaccine Industry Impact
Chapter 2 Global Polio Vaccine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Polio Vaccine (Volume and Value) by Type
2.1.1 Global Polio Vaccine Consumption and Market Share by Type (2016-2021)
2.1.2 Global Polio Vaccine Revenue and Market Share by Type (2016-2021)
2.2 Global Polio Vaccine (Volume and Value) by Application
2.2.1 Global Polio Vaccine Consumption and Market Share by Application (2016-2021)
2.2.2 Global Polio Vaccine Revenue and Market Share by Application (2016-2021)
2.3 Global Polio Vaccine (Volume and Value) by Regions
2.3.1 Global Polio Vaccine Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Polio Vaccine Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Polio Vaccine Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Polio Vaccine Consumption by Regions (2016-2021)
4.2 North America Polio Vaccine Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Polio Vaccine Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Polio Vaccine Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Polio Vaccine Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Polio Vaccine Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Polio Vaccine Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Polio Vaccine Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Polio Vaccine Sales, Consumption, Export, Import (2016-2021)
4.10 South America Polio Vaccine Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Polio Vaccine Market Analysis
5.1 North America Polio Vaccine Consumption and Value Analysis
5.1.1 North America Polio Vaccine Market Under COVID-19
5.2 North America Polio Vaccine Consumption Volume by Types
5.3 North America Polio Vaccine Consumption Structure by Application
5.4 North America Polio Vaccine Consumption by Top Countries
5.4.1 United States Polio Vaccine Consumption Volume from 2016 to 2021
5.4.2 Canada Polio Vaccine Consumption Volume from 2016 to 2021
5.4.3 Mexico Polio Vaccine Consumption Volume from 2016 to 2021
Chapter 6 East Asia Polio Vaccine Market Analysis
6.1 East Asia Polio Vaccine Consumption and Value Analysis
6.1.1 East Asia Polio Vaccine Market Under COVID-19
6.2 East Asia Polio Vaccine Consumption Volume by Types
6.3 East Asia Polio Vaccine Consumption Structure by Application
6.4 East Asia Polio Vaccine Consumption by Top Countries
6.4.1 China Polio Vaccine Consumption Volume from 2016 to 2021
6.4.2 Japan Polio Vaccine Consumption Volume from 2016 to 2021
6.4.3 South Korea Polio Vaccine Consumption Volume from 2016 to 2021
Chapter 7 Europe Polio Vaccine Market Analysis
7.1 Europe Polio Vaccine Consumption and Value Analysis
7.1.1 Europe Polio Vaccine Market Under COVID-19
7.2 Europe Polio Vaccine Consumption Volume by Types
7.3 Europe Polio Vaccine Consumption Structure by Application
7.4 Europe Polio Vaccine Consumption by Top Countries
7.4.1 Germany Polio Vaccine Consumption Volume from 2016 to 2021
7.4.2 UK Polio Vaccine Consumption Volume from 2016 to 2021
7.4.3 France Polio Vaccine Consumption Volume from 2016 to 2021
7.4.4 Italy Polio Vaccine Consumption Volume from 2016 to 2021
7.4.5 Russia Polio Vaccine Consumption Volume from 2016 to 2021
7.4.6 Spain Polio Vaccine Consumption Volume from 2016 to 2021
7.4.7 Netherlands Polio Vaccine Consumption Volume from 2016 to 2021
7.4.8 Switzerland Polio Vaccine Consumption Volume from 2016 to 2021
7.4.9 Poland Polio Vaccine Consumption Volume from 2016 to 2021
Chapter 8 South Asia Polio Vaccine Market Analysis
8.1 South Asia Polio Vaccine Consumption and Value Analysis
8.1.1 South Asia Polio Vaccine Market Under COVID-19
8.2 South Asia Polio Vaccine Consumption Volume by Types
8.3 South Asia Polio Vaccine Consumption Structure by Application
8.4 South Asia Polio Vaccine Consumption by Top Countries
8.4.1 India Polio Vaccine Consumption Volume from 2016 to 2021
8.4.2 Pakistan Polio Vaccine Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Polio Vaccine Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Polio Vaccine Market Analysis
9.1 Southeast Asia Polio Vaccine Consumption and Value Analysis
9.1.1 Southeast Asia Polio Vaccine Market Under COVID-19
9.2 Southeast Asia Polio Vaccine Consumption Volume by Types
9.3 Southeast Asia Polio Vaccine Consumption Structure by Application
9.4 Southeast Asia Polio Vaccine Consumption by Top Countries
9.4.1 Indonesia Polio Vaccine Consumption Volume from 2016 to 2021
9.4.2 Thailand Polio Vaccine Consumption Volume from 2016 to 2021
9.4.3 Singapore Polio Vaccine Consumption Volume from 2016 to 2021
9.4.4 Malaysia Polio Vaccine Consumption Volume from 2016 to 2021
9.4.5 Philippines Polio Vaccine Consumption Volume from 2016 to 2021
9.4.6 Vietnam Polio Vaccine Consumption Volume from 2016 to 2021
9.4.7 Myanmar Polio Vaccine Consumption Volume from 2016 to 2021
Chapter 10 Middle East Polio Vaccine Market Analysis
10.1 Middle East Polio Vaccine Consumption and Value Analysis
10.1.1 Middle East Polio Vaccine Market Under COVID-19
10.2 Middle East Polio Vaccine Consumption Volume by Types
10.3 Middle East Polio Vaccine Consumption Structure by Application
10.4 Middle East Polio Vaccine Consumption by Top Countries
10.4.1 Turkey Polio Vaccine Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Polio Vaccine Consumption Volume from 2016 to 2021
10.4.3 Iran Polio Vaccine Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Polio Vaccine Consumption Volume from 2016 to 2021
10.4.5 Israel Polio Vaccine Consumption Volume from 2016 to 2021
10.4.6 Iraq Polio Vaccine Consumption Volume from 2016 to 2021
10.4.7 Qatar Polio Vaccine Consumption Volume from 2016 to 2021
10.4.8 Kuwait Polio Vaccine Consumption Volume from 2016 to 2021
10.4.9 Oman Polio Vaccine Consumption Volume from 2016 to 2021
Chapter 11 Africa Polio Vaccine Market Analysis
11.1 Africa Polio Vaccine Consumption and Value Analysis
11.1.1 Africa Polio Vaccine Market Under COVID-19
11.2 Africa Polio Vaccine Consumption Volume by Types
11.3 Africa Polio Vaccine Consumption Structure by Application
11.4 Africa Polio Vaccine Consumption by Top Countries
11.4.1 Nigeria Polio Vaccine Consumption Volume from 2016 to 2021
11.4.2 South Africa Polio Vaccine Consumption Volume from 2016 to 2021
11.4.3 Egypt Polio Vaccine Consumption Volume from 2016 to 2021
11.4.4 Algeria Polio Vaccine Consumption Volume from 2016 to 2021
11.4.5 Morocco Polio Vaccine Consumption Volume from 2016 to 2021
Chapter 12 Oceania Polio Vaccine Market Analysis
12.1 Oceania Polio Vaccine Consumption and Value Analysis
12.2 Oceania Polio Vaccine Consumption Volume by Types
12.3 Oceania Polio Vaccine Consumption Structure by Application
12.4 Oceania Polio Vaccine Consumption by Top Countries
12.4.1 Australia Polio Vaccine Consumption Volume from 2016 to 2021
12.4.2 New Zealand Polio Vaccine Consumption Volume from 2016 to 2021
Chapter 13 South America Polio Vaccine Market Analysis
13.1 South America Polio Vaccine Consumption and Value Analysis
13.1.1 South America Polio Vaccine Market Under COVID-19
13.2 South America Polio Vaccine Consumption Volume by Types
13.3 South America Polio Vaccine Consumption Structure by Application
13.4 South America Polio Vaccine Consumption Volume by Major Countries
13.4.1 Brazil Polio Vaccine Consumption Volume from 2016 to 2021
13.4.2 Argentina Polio Vaccine Consumption Volume from 2016 to 2021
13.4.3 Columbia Polio Vaccine Consumption Volume from 2016 to 2021
13.4.4 Chile Polio Vaccine Consumption Volume from 2016 to 2021
13.4.5 Venezuela Polio Vaccine Consumption Volume from 2016 to 2021
13.4.6 Peru Polio Vaccine Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Polio Vaccine Consumption Volume from 2016 to 2021
13.4.8 Ecuador Polio Vaccine Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Polio Vaccine Business
14.1 Sanofi
14.1.1 Sanofi Company Profile
14.1.2 Sanofi Polio Vaccine Product Specification
14.1.3 Sanofi Polio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Bio-Med
14.2.1 Bio-Med Company Profile
14.2.2 Bio-Med Polio Vaccine Product Specification
14.2.3 Bio-Med Polio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Serum Institute
14.3.1 Serum Institute Company Profile
14.3.2 Serum Institute Polio Vaccine Product Specification
14.3.3 Serum Institute Polio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 GSK
14.4.1 GSK Company Profile
14.4.2 GSK Polio Vaccine Product Specification
14.4.3 GSK Polio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Panacea Biotec Ltd
14.5.1 Panacea Biotec Ltd Company Profile
14.5.2 Panacea Biotec Ltd Polio Vaccine Product Specification
14.5.3 Panacea Biotec Ltd Polio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Bibcol
14.6.1 Bibcol Company Profile
14.6.2 Bibcol Polio Vaccine Product Specification
14.6.3 Bibcol Polio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 IMBCA
14.7.1 IMBCA Company Profile
14.7.2 IMBCA Polio Vaccine Product Specification
14.7.3 IMBCA Polio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Tiantan Biological
14.8.1 Tiantan Biological Company Profile
14.8.2 Tiantan Biological Polio Vaccine Product Specification
14.8.3 Tiantan Biological Polio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Halfkin Bio-Pharmaceuticals
14.9.1 Halfkin Bio-Pharmaceuticals Company Profile
14.9.2 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Specification
14.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Polio Vaccine Market Forecast (2022-2027)
15.1 Global Polio Vaccine Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Polio Vaccine Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Polio Vaccine Value and Growth Rate Forecast (2022-2027)
15.2 Global Polio Vaccine Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Polio Vaccine Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Polio Vaccine Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Polio Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Polio Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Polio Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Polio Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Polio Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Polio Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Polio Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Polio Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Polio Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Polio Vaccine Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Polio Vaccine Consumption Forecast by Type (2022-2027)
15.3.2 Global Polio Vaccine Revenue Forecast by Type (2022-2027)
15.3.3 Global Polio Vaccine Price Forecast by Type (2022-2027)
15.4 Global Polio Vaccine Consumption Volume Forecast by Application (2022-2027)
15.5 Polio Vaccine Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Executive Summary
Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...
Overview of the Global Vaccine Supply Chain Solutions Market:
The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...
Overview of the Global Digital Vaccine Tracking System Market:
The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...
Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...
Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...
North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...
Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...
The global Whole Cell Cholera Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...
The global Viral Vaccine Media market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The global Vero Cell Rabies Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...